Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy

Similar documents
Despite major advances in our understanding, as well as. Reviews. Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy

European Society of Cardiology Congress DONOR AGE NEGATIVELY INFLUENCES THE CYTOPROTECTIVE PARACRINE EFFECTS EXERTED BY HUMAN MESENCHYMAL STEM CELLS

ENDOGENOUS CARDIAC STEM CELLS IN THE REGENERATION OF ACUTE AND CHRONIC ISCHEMIC MYOCARDIUM

E. Cervio, P. Danieli, C. Ciuffreda, F. Pisano, M. Roccio, M. Gnecchi. The authors have no financial disclosures to declare

Stem Cell Therapy for Heart Disease Revisited: the Paracrine Paradigm

Myocardial infarction

Mesenchymal Stem Cells to Repair Vascular Damage after Chemotherapy: Past, Present and Future

Mesenchymal Stem Cells and Cancer: Their Interplay

Resident cardiac stem cells: how to find and use them

Stem Cells. Keith Channon. Department of Cardiovascular Medicine University of Oxford John Radcliffe Hospital, Oxford

Cell implantation after myocardial infarction: a 10 years experience from the ICREC laboratory

Supporting Information. Calculation of the relative contributions of myocyte proliferation, stem cell. Supporting Information Fig 1 (page 9)

Transplanted Donor Cells Rescue Contra-Lateral Chemo-ablated Muscle Bed

Cardiomyocyte progenitor cell-derived exosomes stimulate migration of endothelial cells

Reprogramming through micrornas Stefanie Dimmeler

Journal Club Semmler Lorenz

Research progress of adult stem cells and clinical applications

Journal Club WS 2012/13 Stefanie Nickl

Regenerative Medicine for Cardiomyocytes

THESIS. ROMANIAN ACADEMY Institute of Cellular Biology and Pathology Nicolae Simionescu, Bucharest

Promoting Fracture Healing Through Systemic or Local Administration of Allogeneic Mesenchymal Stem Cells

Stem Cell Death and Survival in the Regenerating Heart

A brief review: adipose-derived stem cells and their therapeutic potential in cardiovascular diseases

Cell therapy: enhancing the therapeutic potential of cardiac progenitors for delivery post myocardial infarction. Rita Alonaizan

Mesenchymal Stem Cells

Cell-based therapy for prevention and reversal of myocardial remodeling

Use of Adipose-Derived Stem Cells in Regenerative Therapy. David Euhus, MD Professor of Surgery UT Southwestern Medical Center at Dallas

Stem Cell Therapy Concept. Pleuripotent Stromal Cells 8/8/2011. Use of Adipose-Derived Stem Cells in Regenerative Therapy

Harnessing the Mesenchymal Stem Cell Secretome for the Treatment of Cardiovascular Disease

Exosomes secreted by Human Cardiac Progenitors contain mirna with cardioprotective and proangiogenic activities

Citation for published version (APA): Velde, S. V. D. (2006). Stem cell-mediated regeneration of the infarcted heart: inflammation rules? s.n.

Hypoxia-Dependent Epigenetic Modifications in the Pulmonary Vasculature

Review Article Stem Cell Therapy in Acute Myocardial Infarction: A Pot of Gold or Pandora s Box

PHOSPHODIESTERASE-5 INHIBITION: A NOVEL STRATEGY TO IMPROVE STEM CELL THERAPY IN THE HEART

Cardiac Myocytes are Recruited by Bone Marrow-Derived Cells in Intact Murine Heart

Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction

Review. More Than Tiny Sacks. Stem Cell Exosomes as Cell-Free Modality for Cardiac Repair

DOWNLOAD PDF CARDIAC REMODELING AND CELL DEATH IN HEART FAILURE

Role of Inflammation in Pulmonary Hypertension

PhD THESIS FACTORS MODULATING THE THERAPEUTIC POTENTIAL OF ENDOTHELIAL PROGENITOR CELLS FOR NEOVASCULARIZATION OF ISCHEMIC TISSUES

1. Cardiomyocytes and nonmyocyte. 2. Extracellular Matrix 3. Vessels שאלה 1. Pathobiology of Heart Failure Molecular and Cellular Mechanism

Stem cells for cardiac repair

Vice Dean and Professor of Medicine

Reviews. This Review is part of a thematic series on Cellular Therapy, which includes the following articles:

SUPPLEMENTARY INFORMATION

Myocardial Regeneration and Stem Cell Repair

Topically Applicable Stromal Cell Growth Factors - Encapsulated Cosmeceuticals

Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts

Review. Mesenchymal Stem Cells: Biology, Pathophysiology, Translational Findings, and Therapeutic Implications for Cardiac Disease

stem cell products Basement Membrane Matrix Products Rat Mesenchymal Stem Cell Growth and Differentiation Products

Masashi Tanaka, Tanaka M Tanaka M Tanaka M Tanaka M Tanaka M

Cardiovascular cell therapy: next step is a custom work?

Remodeling the failing heart: : the biology and future treatment options

MicroRNA as a Biological Drug and Recovery of Myocardial Infarction. Exosome

Protocol. Progenitor Cell Therapy for the Treatment of Damaged Myocardium due to Ischemia

Thyroid hormone and cardiac regeneration: from Prometheus myth to reality

Journal of the American College of Cardiology Vol. 59, No. 10, by the American College of Cardiology Foundation ISSN /$36.

Dr. Alexander Lyon Senior Lecturer and Consultant Cardiologist Clinical Lead in Cardio-Oncology Royal Brompton Hospital, London UK

Targeting micrornas to promote cardiac repair and cardiomyocyte proliferation as a potential regenerative therapeutic approach

שינויים מולקולאריים ומבניים באי ספיקת לב אפשרויות לטיפול עתידני

Therapeutic Potential of Human Umbilical Cord Derived Stem Cells in a Rat Myocardial Infarction Model

Cardiac Regeneration. Piero Anversa, MD, Annarosa Leri, MD, Jan Kajstura, PHD Valhalla, New York THE HEART AS A POST-MITOTIC ORGAN: THE CONTROVERSY

UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II FACOLTA DI MEDICINA E CHIRURGIA

Strategic Research Development in Stem Cell and Regenerative Medicine in HKU Professor Sum-ping Lee Dean HKU Li Ka Shing Faculty of Medicine

Stem Cell Therapy in Acute Myocardial Infarction: hype or reality?

Despite major advances in our understanding and therapy of

The Jay Cohn Lecture 2012: Therapeutic regeneration of the injured heart

Devices are So Old School: The New World of Myocardial Regeneration

Clinical Applications of Stem Cell Therapy for Regenerating The Heart

Multimodality Imaging in Cardiac Stem Cell Research

TRANSLATIONAL AND CLINICAL RESEARCH

Chapter 2 The Immunogenicity of ES Cells and Their Differentiated Progeny

Cardiovascular disease is the leading cause of mortality. Review. Use of Mesenchymal Stem Cells for Therapy

REVIEW Hematopoietic, vascular and cardiac fates of bone marrow-derived stem cells

Reperfusion Injury: How Can We Reduce It?

PROCHONDRIX CARTILAGE RESTORATION MATRIX CONTAINS GROWTH FACTORS NECESSARY FOR HYALINE CARTILAGE REGENERATION

Marrow Stromal Cells for Cell-Based Therapy: The Role of Antiinflammatory Cytokines in Cellular Cardiomyoplasty

Progenitor Cell Therapy for the Treatment of Damaged Myocardium due to Ischemia. Original Policy Date

Stem Cells and The Endometrium. Director, Division of Reproductive Endocrinology and infertility

renoprotection therapy goals 208, 209

No option-patients : Is angiogenesis with gene or cell therapy still an option?

Tissue renewal and Repair. Nisamanee Charoenchon, PhD Department of Pathobiology, Faculty of Science

Review Article Present and Future Perspectives on Cell Sheet-Based Myocardial Regeneration Therapy

9/23/2017. Prof. Steven S. Saliterman. Department of Biomedical Engineering, University of Minnesota

CRIPTO-1 A POSSIBLE NEW BIOMARKER IN GLIOBLASTOMA MULTIFORME PIA OLESEN, MD, PHD STUDENT

Amniotic fluid stem cells provide considerable advantages in epidermal. regeneration: B7H4 creates a moderate inflammation

Transplantation. Immunology Unit College of Medicine King Saud University

Supplementary material page 1/10

Cardiomyocyte proliferation and progenitor cell recruitment underlie therapeutic regeneration after myocardial infarction in the adult mouse heart

Coronary heart disease and heart failure continue to be

Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function

Cellular and molecular mechanism of heart failure

Protocol. Progenitor Cell Therapy for the Treatment of Damaged Myocardium Due to Ischemia

Stem cell therapy for cardiovascular disease: the demise of alchemy and rise of pharmacology

The Process of Angiogenesis & Inhibition of Angiogenesis and/or Lymphangiogenesis

Structural abnormalities of the heart and vascular system in CKD & Dialysis - Thick but weak

Therapeutic effects of human STRO-3-selected mesenchymal precursor cells and their soluble factors in experimental myocardial ischemia

Muscle Stem Cell Therapy for the Treatment of DMD Associated Cardiomyopathy

Professor Harvey White. Interventional Cardiologist Auckland

Transcription:

Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy Massimiliano Gnecchi, Zhiping Zhang, Aiguo Ni, Victor J. Dzau Circulation Research 2008 Nov 21;103(11):1204-19

Introduction(1) After AMI all of the cardiac tissue served by the infarction related artery undergoes necrosis or apoptosis The endogenous regenerative capacity of the heart is not able to replenish a significant loss of tissue such as after AMI 1 Therapeutic myocardial regeneration might be achieved by using adult stem cells (ASC) 2 1 Beltrami et al, N Engl J Med 2001;344:1750-1757 2 Beltrami et al, Cell 2003;114:763-776

Gnecchi et al, Circ. Res. 2008: 103:1204-1219 Stem Cell Therapy

Stem Cell Therapy Cardiac stem cells (CSC) when injected into infarcted murine hearts are able to differentiate into endothelial cells (EC) and vascular smooth muscle cells (VSMC) 1 Leri et al, Physiol Rev. 2005;85:1373-1416 Messina et al, Circ Res 2004;95:911-921

Stem Cell Therapy Bone marrow derived stem cells injected into mouse hearts after AMI were able to engraft, transdifferentiate into cardiac cells and regenerate 60% of the infarcted area with newly formed cardiomyocytes 1 Orlic et al, Nature 2001;410:701-705

Stem Cell Therapy It has been shown that the number of newly generated cardiomyocytes is too low to explain significant functional improvement 1 The functional benefits might be related to secretion of soluble factors, acting in a paracrine fashion 1 1 Gnecchi et al, Circ. Res. 2008: 103:1204-1219

Gnecchi et al, Circ. Res. 2008: 103:1204-1219 Paracrine Effects

Myocardial Protection Conditioned medium was collected from MSCs after 12 h of exposure either to normoxia or hypoxia GFP-MSC MSC overexpressing Akt1 ARVC incubation under hypoxic conditions Gnecchi et al, Circ. Res. 2008;103:1204-1219

Myocardial Protection Gnecchi et al, Circ. Res. 2008: 103:1204-1219

Myocardial Protection Evaluation of some cadidate genes encoding for molecules known to be released by MSC by quanitative RT-PCR Significant upregulation of (in Akt-MSC): VEGF, HGF, IGF-1, Thymosin beta-4 Gnecchi et al, Circ. Res. 2008: 103:1204-1219

Myocardial Protection Gnecchi et al, Circ. Res. 2008: 103:1204-1219

Gnecchi et al, Circ. Res. 2008: 103:1204-1219 Paracrine Effects

Cardiac Regeneration ASCs, when injected into the injured myocardium, are able to: Proliferate and transdifferentiate into cardiomyocytes 1 Fuse with native cardiomyocytes and regenerate the lost myocardium 1 Activate resident cardiac stem cells and stimulate cardiomyocytic replication via paracrine action 1 Dimmeler et al, J Clin Invest 2005;115:572-583

Cardiac Regeneration Intramyocardial administration of VEGF, HGF and IGF-1 at the infarct border zone induces CSC migration, proliferation and differentiation 1 1 Linke et al, Proc Natl Acad Sci U S A. 2005;102:8966 8971 2 Gnecchi et al, FASEB J. 2006;20:661 669.

Cardiac Regeneration Wollert et al.; Lancet 2004; 364: 141-148

Conclusion Transplantation of stem cells for their paracrine effects still represents a reasonable strategy multiple factors might be functioning together If specific paracrine cell-derived factors will be identified protein based therapy might be more easily translated into clinical benefits than cell based therapy

Future in Stem Cell Therapy for the Heart Choice of cell type to administer: the cardiomyogenic potentiality of each ASC is not explored yet Extensive loss of the cells once transplanted in combination with the extreme rareness of specific stem cell populations Idea of improving cell survival by overexpressing protective genes: e.g. combination of genetic modification and preconditioning with different cytokines Cell administration immediately after infarction or after the inflammatory process has subsided?

Future in Stem Cell Therapy for the Heart Age of the patient and presence of desease status adversely influences characteristics of ASCs using allogenic cells from young and healthy donors? Cell rejection? MSC display an immunoprivileged phenotype! 1 Introduction of standart operating procedures and nomenclature among different laboratories will be mandatory to optimize our understanding of stem cell biology 1 Dzau et al, Hypertension. 2005;46:7 18

Thank you for your attention!